Press

We invest in and build companies that change lives. See how our ventures are producing real results that are changing the landscape of medicine.

Featured Story

Fierce Biotech: March 19, 2024

Engrail closes $157M series B, fueled by investors’ renewed interest in neuropsychiatry

READ STORY